Diffuse non-hodgkin’s lymphoma, immunoblastic clinical)
Diffuse non-hodgkin’s lymphoma, large cell clinical)
Immunoblastic high grade lymphoma, stage 1
Immunoblastic high grade lymphoma, stage 2
Immunoblastic high grade lymphoma, stage 3
Immunoblastic high grade lymphoma, stage 4
Lymphoma, diffuse large b cell, non hodgkins
Lymphoma, immunoblastic, high grade
Lymphoma, immunoblastic, high grade, stage 1
Lymphoma, immunoblastic, high grade, stage 2
Lymphoma, immunoblastic, high grade, stage 3
Lymphoma, immunoblastic, high grade, stage 4
Reticulosarcoma
C83.30 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM C83.30 became effective on October 1, 2022.
This is the American ICD-10-CM version of C83.30 – other international versions of ICD-10 C83.30 may differ.